The transmembrane and intracellular protein tyrosine phosphatases (PTPs) play an essential role as signal transduction proteins involved in various cellular processes including division, proliferation and differentiation. As such, their activity must be strictly regulated to avoid nonspecific tyrosine dephosphorylation of cellular proteins. The intracellular P]Ps possess a diversity of protein sequences outside the catalytic domain that appear to serve as 'zip codes' specifically 'addressing' these proteins to defined subceliular compartments. These localization strategies are proposed to function as a regulatory mechanism, defining the substrate specificity and function of the intracellular PTPs.
(where X is any amino acid). This region is the signature sequence of most PTPs. Site-directed mutagenesis and trapping experiments have shown that the cysteinyi residue within this motif is essential for phosphatase activity and forms a thiol-phosphate intermediate during catalytic turnover 1. Interestingly, this catalytic domain bears no resemblance to that of the serine/threonine phosphatases or o( the alkaline or acid phosphatases.
Transmembrane PTPs possess an extracellular domain, a single transmembrane domain and norma, dy two catalytic domains followed, by a short carboxy-terminal segment. At present, the human PTP[5 and tl'~e Drosophila DPTPI0D are the only transmembrane proteins that have a single catalytic domain. Unlike the cytoplasmic tail, the extracellular domains of these proteins are highly divergent, with small glycosylated segments (human PTPa and e), tandem repeats of immunoglobulin-like and fibropectin type Ill domains similar to N.CAM molecules [leucocyte common antigen related molecule OAR), PTP,~], or alternately spliced lengths of sequence containing N-and O.linked carbohydrates (CD45). These extracellulax features suggest that the activity of these PTPs might be modulated by ligands. Recently, it was shown that the homophilic binding of PTPp~ can mediate cell-cell aggregation 3,4. This suggests theft the extracellular domain of this PTP can serve as its own ligand and could potentially function to regulate ceE-celi interactions.
Thr: distinguishing feature of the intracellular PTPs is the diversity of de, mains flanking a single catalytic (iomain (Fig. 1) . One of the principle functions of these flanking sequences, or zip codes, appears to be the targeting of the enzyme to specific intracellular locations. These include: (1) membraneassociation domains, (2) nucleaxlocalization domains, (3) Src homology 2 (SH2) domains and (4) cytoskeletalassociation domains. A schematic showing these intracellulax PTPs residing at their proven or hypothesized subcellulax locations within a eukaryotic cell is shown in Fig. 2 . We will discuss each of the PTPs shown in the following sections.
Membrane and nuclear targeting sequences fol PTPs
A number of intracellulax PTPs possess unique sequences downstream of the catalytic domain, which might serve to regulate the targeting of the protein to a subcellular locale and, in some cases, also modulate phosphatase activity. Purification of PTP1B from the human placenta yielded both soluble and particulate forms of the enzyme, (Fig. 3) . Studies employing reporter proteins to determine the importance of this sequence in subcellular targeting have shown that this region is critical and adequate for the cellular localization of full-length PTP1B and PTPI to the endoplasmic reticulum (ER) a.9. Although we can verify the localization of PTPI and PTPIB to the ER, we can only speculate about the functional reasons for this localization. Compartmentalization to the ER could serve merely as a 'way-station' until a cellular stimulus induces translocation of the enzyme to another compartment where it is active. Recent studies have shown that such a scenario might occur following agonist-induced platelet activation IU. The carboxyl terminus of PTP 1B appears to be cleaved, resulting in translocation of the protein from membranes to the cytosol as well as a twofold increase in PTP catalytic activity. While localized to the ER, these PTPs could also dephosphorylate proteins that reside on, or are closely associated with, the ER (Fig. 2) . Tyrosine kinases, such as Ltk n and Src-related tyrosine kinases ~2, are found along the ER, within focal adhesions [regions of plasma membrane and complexed intracellular proteins associated with the extracellular matrix (ECM)] and adherens ]unctions (sites of cell-cell attachment). Recently, a new tyrosine kinase, FAK (focal-adhesion kinase), has been described; it also localizes to focal adhesions in fibroblasts and may associate with 152 c-Src and cytoskeletal proteins such as paxillin and talin 13. PTP1 overexpressed in Src-trans[ormed fibroblasts appears to he localized to focal ~dhesions as well as to the ER 14. One of these PTPs could be localized near, or associated with, these ERand adhesion-specific kinases, and could act to directly regulate kinase activity or that of their substrates.
The human T-cell PTP is an example of an intracellular PTP whose activity appears to be regulated by the presence of its carboxy-terminal sequence. This phosphatase has two carboxy-terminal isoforms: the originally isolated PTP with a long carboxyl terminus rich in hydrophobic amino acids [referred to as T-cell PTP(a) in A novel Drosophila PTP was recently isolated that is targeted to two distinct intracellular locations due to alternative splicing ~7. The gene encoding this phosphatase, known as DPTP61F, undergoes alternative splicing at the 3'-end of the message, resulting in two RNA transcripts that encode proteins with discrete carboxy-terminal tails. The carboxyl terminus of the longer protein, p61/62m, contains 24 hydrophobic amino acids that serve as a membrane-association signal. The shorter isoform, p61/62n, has a sequence containing 11 hydrophilic amino acids within this region that resembles the nuclear-targeting consensus sequence (Fig. 3) . Overexprtssion of p61/62m in COS-1 cells led to membrane localization of the protein to a reticular network (possibly ER) as well as to mitochondrion-like organelles. By contrast, p61/62n localized solely to the nucleus. Kinetic analysis of these two proteins revealed no difference in catalytic activity or substrate specificity. These results suggest that the activity and substrate specificity of these [soforms is determined by their subcellular localization which, in turn, is determined by the carboxy-terminal zip cooe. In addition, the isolation of a nuclear PTP is interesting since it could conceivably function in regulating gene transcription by modulating tyrosinephosphorylated transcription [actors ~8, or in regulating cell-cycle proteins (Fig. 2) .
SH2 domains link PTPs to signaling pathways
The SH2 domain is a conserved sequence motif of approximately 100 amino acids known to have a fundamental role in regulating interactions of cytoplasmic signaling molecules with receptor tyrosine kinases ~9, This domain was originally identified in the v-Src family of non-receptor tyrosine kinases and has since been found in a wide variety of proteins. These include: other non-receptor tyrosine kinases such as Abl; signaling enzymes such as phospholipase C9 and the 85 kDa subunit of phosphoinositide 3-kinase; and the putative oncogenic transcription factor known as Vav. In all of these proteins, the SH2 domain is thought to function as a linker by binding to a phosphotyrosine residue on activated (i.e. autophosphorylated) growth factor receptors, thus bringing together multiple components of the appropriate mitogenic signaling pathway. Several PTPs appear to contain SH2 domains. Two of the SH2-containing PTPs that have been studied in some detail are SH-PTP1, which is expressed predominantly in hemopoietic cells (also referred to as PTP1C, HCP and SHP), and SH-PTP2 (SYP, PTPID, PTP2C and SH-PTP3), which is a ubiquitously expressed protein. These highly homolo-"~ all possess a single cataLy~,~ ,~omain with two tandem amino-terminal SH2 domains (Fig. 1) . Recent studies have shown that these PTPs interact with other signaling molecules such as activated plateletderived growth factor receptor (PDGFR), epidermal growth factor receptor (EGFR) and the insulin receptor substrate 1 (Refs 20-23 ). In addition, mitogenic stimulation of various cell lines with PDGF, EGF or colony stimulating factor-I leads to an increase in tyros[he phosphorylaUon of the PTP protein on an unidentified tyros[no residue.
These studies demonstrate that the SH2 domains enable PTPs to localize to and interact with the phosphotyrosine residues of activated growth factor receptors (Fig. 2) . Once associated with the receptor, the PTP might then function to modulate the transduction of the mitogenic signal within the cell. Since it appears that only a small percentage (0.5-1%) of the SH2-containing PTP in the cell translocates to the receptor following stimulation, this targeting probably serves to place the protein near key substrates. The remaining cytoplasmic protein could be an inactive pool or might interact with other phosphorylated signaling proteins downstream in the pathway. In addition to localizing the PTP to substrates at the membrane, the binding of the PTP to the phosphotyrosine residue of the receptor and the subsequent phosphorylation of the PTP might influence enzyme activity. Preliminary in vitro experiments have shown that,
Figure 2
Distribution of intracellular PTPs within the eukaryotic cell. This schematic shows the distribution of the intracellular PTPs at proven or speculated locations within the cell. Each PTP is pictured as a catalytic 'box' with an associated domain that is the zip code for that compartment. At the plasma membrane we might find a PTP (? PTP), such as PTP1 associating with focal adhesions, along with the adhesion-specific tyrosine kinase FAK. In addition, an SH2-containing PTP, like SH-PTP2, would be associated with an activated growth factor receptor (GFR) as a result of translocation from the cytoplasm following an extracellular mitogenic signal. We might find a cytoskeletal PTP, such as PTPH1, interacting with cytoskeletal matrix proteins. The intracel!ular membrane compartment would be home to PTPIB, which would be lodged in the ER membrane along with the ER tyros[he kinase Ltk.
The membrane isoform of the Drosophila DPTP61F (p61/62m) would also be here, on the ER and/or the mitochondrial membrane. Within the nucleus, we would find the nuclear isoform of DPTP61F (p61/62n) which might function in regulation of gone transcription or cell division. 
Figure 3
Carboxy-terminal sequences of some PTPs regulate membrane and nuclear localization. These PTPs can be thought to possess two major regions: an amino-terminal catalytic region and a carboxy-terminal targeting/regulatory (T/R) region, as pictured. The most carbox~terminal amino acid sequence of the T/R region is shown for the human and rat PTP1B
homologs, for the human T-cell PTP isoforms and for the Drosophila DPTP61F isoforms.
Amino acids boxed in black are charged residues; those boxed in white are hydrophobic residues. The PTPIB homologs have a sequence of 20 hydrophobic residues flanked by charged residues, which resembles a membrane-spanning region. The T-cell PTP isoforms exhibit a long stretch of hydrophobic residues [T-cell PTP(a)] or a shorter stretch of charged residues [T-cell PTP(b)J. The Drosophila PTP, DPTP61F, also has two isoforms: a longer protein exhibiting a potential membrane-spanning region similar to PTPIB (p61/62m) and a shorter form with a potential nuclear localization consensus sequence (p61/62n). 
Cytoskeletal PTPs: Intedor designers of the cell?
A unique amino-terminal targeting domain has L.een identified in several intracellular PTPs which has sequence similarity to known cytoskeletonassociated proteins. These domains within PTPMegl and PTPHI have up to 45% homology with amino-terminal domains in the erythrocyte proteins band 4.1, ezrin and talin, which are all members of the band 4.1 superfamily of cytoskeletal proteins. In general, members of this superfamily are responsible for the association of actin filaments with a complex of proteins at the plasma membrane. These protein associations are critical in the control of cell shape and motility; in defining specialized membrane regions such as synaptic densities; and in stabilizing cell-cell and cell-matrix interactions 27. Band 4.1 binds to the erythrocyte transmembrane proteins band 3, glycophorin C and spectrin, enhancing spectrin-actin affinity. The interaction with band 3 is mediated by amino-terminal sequences, suggesting that similar interactions, involving the amino-terminal domains of the cytoskeletal PTPs with members of this family of cytoskeletal proteins, might occur in the cell. In addition to PTPMegl and PTPH1, a :elated PTP, BA14, has been isolated from bovine adrenal tissue and possesses a similar cytoskeletal-association domain along with five GL(;7 motifs 28. GLGF motifs have been identified in proteins that reside in specialized junctions, such as tight junctions and postsynaptic densities.
The identification of PTPs with domains related to cytoskeletal proteins adds an exciting facet to the regulation of cytoskeleton-plasma-membrane interactions (Fig. 2) . Although the association of these PTPs with such proteins has yet to be pro~d, our present knowledge of the role of tyrosine phosphorylation in the maintenance and modulation of cell-cell and cell-substratum interactions strongly suggests a potential function for PTPs localized to these cellular regions. An example is the sculpting of focal adhesions by the changes in tyrosine phosphorylation of associated proteins t3,2~,3°. Focal adhesions consist of transmembrane proteins known as integrins, which llnk the ECM to an intracellular plaque associated with actin bundles (stress fibers). Attachment of cells to ECM proteins results in tyrosine phosphorylation of multiple intracellular proteins associated with these adhesions including paxillin, tensin, talin, 13-integrin and FAK. Inhibition of cellular tyrosine kinases prevents formation of focal adhesions. It is not hard to imagine a cytoskeleton-associated PTP functioning in this integrinmediated tyrosine phosphorylation, as well as in other cell processes regulated by cytoskeleton-plasma-membrane interactions.
Oventlew
The structural features of the intracellular PTPs and the experimental evidence concerning location-function relationships of these molecules suggests that the targeting of the PTPs is an important mechanism used to modulate PTP activity in the cell. This means of regulatory localization probably serves to define substrate specificity and function. There is growing evidence that such localization strategies are used to regulate many cellular enzymes. The serine/threonine kinases and phosphatases often associate with specific cellular proteins, referred to as targeting subunits, which restrict their subcellular localization, defining the time and place of subsequent catalysis. For example, the well-characterized glycogen-associated protein phosphatase-1 (PP1), involved in the regulation of glycogen metabolizing enzymes, exists as a heterodimer complexed with a glycogen-targeting subunit al. This additional subunit possesses a glycogenbinding domain, a sarcoplasmic reticulure membrane-association domain and phosphorylation sites that, when modified, can regulate the activity of the complexed PP1. Functionally, this is similar to the intraceilular PTPs in which domains serve to confine the enzyme to a specific cellular space. Structurally, these PTPs differ in possessing such domains as a part of the catalytically active protein. At present, it is not known whether or not a similar class of subunit proteins exists that associate with intracellular PTPs, providing additional targeting information and/or regulating catalytic activity. Future research should determine the role of these noncatalytic zip codes in the regulation of PTP activity during various cellular processes.
Sidney and the sage
Sidney the worm felt very put clown As the object of study by a sage of renown; Poked and prodded, his innards exposed, He suffered in silence when with chemicals dosed, 'This invasion of privacy is an outrage,' Thought Sidney, '1 like not the work of this sage, For what he proposes surely ill bodes For me and all other nematodes.' Said the sage to Sidney, 'My vermiform friend, I've learned all about you from front to end, Every cell has its place and provenance too, I have found where they come from and all that they do. You are to me like an open book For with insight and genius I knew how to look, Secure in conviction that determinism Encompasses all without doubt or schism. Now by control of genetic transcription I can change you according to my prescription. Such power no man has had beforeGod-like, they called it, in days of yore,' Asked Sidney, 'Am I merely the sum of my genes, Religion and culture the constructs of memes? t Am I defined without subjective self-A molecular object plucked from the shelf? Are collective unconscious and Freudian dreams Just chemical fluxes in neuronal streams? If all is the outcome of chance mutation How then life's meaning is Art's creation? Despite exegeses and reductionist charts The whole is still greater than the sum of the parts. Molecular accounts of life leave no room In their equations for cogtto ergo sum, Yet past, present and future -all, so they say, Is the dominion of snippets of DNA Whose enthronement, it is plain to see, Is the stuff of a new doxology.' 'Methinks', said Sidney, 'this dogma biological Is a short remove from credo theological.' But the sage was certain his work would unveil The secrets of life -the sought holy grail. Said he, '1 have triumphed, it will be no surprise To receive the call for the Nobel prize,' But when hubris will out the great are cast down, And such was the fate of this sage of renown, For one day he stumbled and fell on his head, So Sidney and friends gathered and ate him instead.
